NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia — Stella

Home/Homozygous Familial Hypercholesterolemia/

View on ClinicalTrials.gov

Recruiting

Back to Homozygous Familial Hypercholesterolemia trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi

Key details

Phase

Very early testing

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Enrollment target

~12 participants

Started

October 2023

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years – 55 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.